Meis1-driven suppression of MIF/CD74 signaling promotes M2 macrophage polarization and protects against inflammatory damage in experimental acute lung injury
Authors:
Open Access
- 20 March 2026
- journal article
- research article
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 42 (1)
Abstract
Acute lung injury (ALI) is marked by dysregulated inflammatory responses, disruption of the alveolar–capillary barrier, and defective tissue repair, in which macrophages function both as drivers of tissue damage and facilitators of resolution. Here, we explored the transcriptional regulation of macrophage polarization in ALI using integrative single-cell and bulk RNA sequencing approaches. Meis1 was identified as a critical transcriptional factor that promotes macrophage skewing toward the M2 phenotype, associated with anti-inflammatory and reparative functions. Mechanistic dissection revealed that Meis1 negatively regulates the MIF/CD74 signaling pathway, thereby limiting pro-inflammatory macrophage activity. Experimental validation in vitro confirmed that Meis1 enhances expression of M2-associated markers while suppressing inflammatory cytokine release. In vivo studies using a murine ALI model demonstrated that Meis1 overexpression alleviates lung inflammation, reduces tissue damage, and accelerates structural repair. These findings establish Meis1 as a key modulator of immune cell fate in injured lungs. Through inhibition of MIF/CD74 signaling, Meis1 constrains inflammatory toxicity and supports tissue repair, revealing a novel regulatory pathway that may be exploited for treating ALI and related inflammatory lung conditions. Graphical AbstractKeywords
Funding Information
- National Natural Science Foundation of China (grant number No.82470042)
- Liaoning Provincial Joint Science and Technology Plan (grant number 2023JH2/101800021)
- Basic Scientific Research Project of Liaoning Provincial Department of Education (grant number LJKMZ20221186)
- Shenyang Municipal Public Health Research and Development Special Project (grant number 22-321-33-14)
- Liaoning Provincial Doctoral Research Start-up Fund (2025080074-JH3/101)
This publication has 63 references indexed in Scilit:
- Meis1 Targets Protein Tyrosine Phosphatase Receptor J in Fibroblast to Retard Chronic Kidney Disease ProgressionAdvanced Science, 2024
- Pyroptosis and polarization of macrophages in septic acute lung injury induced by lipopolysaccharide in miceImmunity, Inflammation and Disease, 2024
- Targeting immunometabolism against acute lung injuryClinical Immunology, 2023
- hUC‐MSCs exosomal miR‐451 alleviated acute lung injury by modulating macrophage M2 polarization via regulating MIF‐PI3K‐AKT signaling pathwayEnvironmental Toxicology, 2022
- Macrophage migration inhibitory factor (MIF): A multifaceted cytokine regulated by genetic and physiological strategiesPharmacology & Therapeutics, 2022
- Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndromeActa Pharmaceutica Sinica B, 2022
- SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosisCell, 2021
- Methyl eugenol attenuates liver ischemia reperfusion injury via activating PI3K/Akt signalingInternational Immunopharmacology, 2021
- Inhibition of HIF-1a-mediated TLR4 activation decreases apoptosis and promotes angiogenesis of placental microvascular endothelial cells during severe pre-eclampsia pathogenesisPlacenta, 2019
- Sodium butyrate alleviates LPS-induced acute lung injury in mice via inhibiting HMGB1 releaseInternational Immunopharmacology, 2018